Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung disease
J. Eaden (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), N. Weatherly (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), J. Lithgow (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), S. Renshaw (Sheffield, United Kingdom), M. Buch (Leeds, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Skeoch (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), G. Parker (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom)
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Eaden (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), N. Weatherly (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), J. Lithgow (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), S. Renshaw (Sheffield, United Kingdom), M. Buch (Leeds, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Skeoch (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), G. Parker (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom). Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung disease. 3158
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: